277
Participants
Start Date
December 13, 2018
Primary Completion Date
April 21, 2020
Study Completion Date
September 28, 2020
Tralokinumab
Tralokinumab is a human recombinant monoclonal antibody of the IgG4 subclass that specifically binds to human IL-13 and blocks interaction with the IL-13 receptors. It is presented as a liquid formulation for subcutaneous (SC) administration.
Placebo
Placebo contains the same excipients in the same concentration only lacking tralokinumab.
Leo Pharma Investigationel Site, Brussels
Leo Pharma Investigationel Site, Brussels
Leo Pharma Investigationel Site, Edegem
Leo Pharma Investigationel Site, Leuven
Leo Pharma Investigationel Site, Liège
Leo Pharma Investigationel Site, Loverval
Leo Pharma Investigationel Site, Kortrijk
Leo Pharma Investigationel Site, Ghent
Leo Pharma Investigationel Site, Maldegem
Leo Pharma Investigationel Site, Prague
Leo Pharma Investigationel Site, Córdoba
Leo Pharma Investigationel Site, Prague
Leo Pharma Investigationel Site, Granada
Leo Pharma Investigationel Site, Kiel
Leo Pharma Investigationel Site, Valence
Leo Pharma Investigationel Site, Madrid
Leo Pharma Investigationel Site, Madrid
Leo Pharma Investigationel Site, Madrid
Leo Pharma Investigationel Site, Hanover
Leo Pharma Investigationel Site, Pamplona
Leo Pharma Investigationel Site, Karlovy Vary
Leo Pharma Investigationel Site, Grenoble
Leo Pharma Investigationel Site, Seville
Leo Pharma Investigationel Site, Bilbao
Leo Pharma Investigationel Site, Dülmen
Leo Pharma Investigationel Site, Bad Bentheim
Leo Pharma Investigationel Site, Osnabrück
Leo Pharma Investigationel Site, Aachen
Leo Pharma Investigationel Site, Pardubice
Leo Pharma Investigationel Site, Mainz
Leo Pharma Investigationel Site, Selters
Leo Pharma Investigationel Site, Frankfurt
Leo Pharma Investigationel Site, Pierre-Bénite
Leo Pharma Investigationel Site, Ostrava
Leo Pharma Investigationel Site, Paris
Leo Pharma Investigationel Site, München
Leo Pharma Investigationel Site, Augsburg
Leo Pharma Investigationel Site, Ghent
Leo Pharma Investigationel Site, Herstal
Leo Pharma Investigationel Site, Kutná Hora
Leo Pharma Investigationel Site, Prague
Leo Pharma Investigationel Site, Prague
Leo Pharma Investigationel Site, Prague
Leo Pharma Investigationel Site, Nice
Leo Pharma Investigationel Site, Berlin
Leo Pharma Investigationel Site, Dresden
Leo Pharma Investigationel Site, Halle
Leo Pharma Investigationel Site, Jena
Leo Pharma Investigationel Site, Bialystok
Leo Pharma Investigationel Site, Bochnia
Leo Pharma Investigationel Site, Bydgoszcz
Leo Pharma Investigationel Site, Gdansk
Leo Pharma Investigationel Site, Krakow
Leo Pharma Investigationel Site, Krakow
Leo Pharma Investigationel Site, Krakow
Leo Pharma Investigationel Site, Lodz
Leo Pharma Investigationel Site, Lodz
Leo Pharma Investigationel Site, Lublin
Leo Pharma Investigationel Site, Poznan
Leo Pharma Investigationel Site, Rzeszów
Leo Pharma Investigationel Site, Warsaw
Leo Pharma Investigationel Site, Warsaw
Leo Pharma Investigationel Site, Warsaw
Leo Pharma Investigationel Site, Wroclaw
Leo Pharma Investigationel Site, Alicante
Leo Pharma Investigationel Site, Barcelona
Leo Pharma Investigationel Site, Barcelona
Leo Pharma Investigationel Site, Barcelona
Leo Pharma Investigationel Site, Bradford
Leo Pharma Investigationel Site, Cottingham
Leo Pharma Investigationel Site, Kirkcaldy
Leo Pharma Investigationel Site, London
Leo Pharma Investigationel Site, Southampton
Leo Pharma Investigationel Site, Wakefield
Lead Sponsor
LEO Pharma
INDUSTRY